术前深度单采自体红细胞和/或血小板储血技术应用中国专家共识  

Chinese Expert Consensus on Preoperative Advanced Autologous Apheresis

作　　者：中国输血协会临床输血管理学专业委员会 陈冠伊 查占山 欧阳锡林 李志强[3] Chinese Blood Transfusion Association Clinical Transfusion Management Committee

机构地区：[1]不详 [2]中国人民解放军海军军医大学第一附属医院 [3]上海交通大学医学院附属第六人民医院 [4]中国人民解放军总医院第四医学中心

出　　处：《临床输血与检验》2024年第2期145-155,共11页Journal of Clinical Transfusion and Laboratory Medicine

摘　　要：术前深度单采自体红细胞和/或血小板储血技术(简称:深度单采自体储血技术)是储存式自体输血的一种新型方式,近年来该技术在国内多家医院相继开展,但其实施过程与质量控制方面尚未形成共识或技术操作规范。为此,中国输血协会临床输血管理学专业委员会组织全国相关领域专家,对术前深度单采自体储血技术的技术原理、准入要求、适应证、禁忌证、操作要点、不良反应防治、采集血液质量评价及处置等方面广泛深入探讨后,共同制定本共识。旨在更好地进行患者自体血液管理,同时为医护人员更加安全、规范地实施术前深度单采自体储血技术工作提供依据。Preoperative Advanced Autologous Apheresis(AAA)is a new type of preoperative autologous blood donation.In recent years,this technology has been introduced in many hospitals across the country.However,there has yet to be a consensus or technical standard for its implementation process and quality control.To address this,the Chinese Blood Transfusion Association Clinical Transfusion Management Committee organized experts from related fields nationwide to extensively and deeply discuss the technical principles,entry requirements,indications,contraindications,operational key points,adverse reaction prevention and treatment,and blood quality evaluation and disposition of preoperative Advanced Autologous Apheresis,and jointly formulated this consensus.The aim is to better manage autologous blood for patients and to provide a basis for medical staff to implement preoperative Advanced Autologous Apheresis more safely and standardized.

关 键 词：术前自体储血 单采自体红细胞 单采自体血小板 质量控制 专家共识 

分 类 号：R457[医药卫生—治疗学]